Cigir B Avci Selected Research

3- ((4- (6- bromo- 2- (4- (4- methylpiperazin- 1- yl)phenyl)- 3H- imidazo(4,5- b)pyridin- 7- yl)piperazin- 1- yl)methyl)- 5- methylisoxazole

1/2021

The Evaluation of Effect of Aurora Kinase Inhibitor CCT137690 in Melanoma and Melanoma Cancer Stem Cell.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cigir B Avci Research Topics

Disease

2	Neoplasms (Cancer) 01/2021 - 01/2020
1	Melanoma (Melanoma, Malignant) 01/2021
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021
1	Primary Myelofibrosis (Myelosclerosis) 01/2020
1	Multiple Myeloma 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2020

Drug/Important Bio-Agent (IBA)

1	Dasatinib (BMS 354825)FDA Link 01/2021
1	Aurora KinasesIBA 01/2021
1	3- ((4- (6- bromo- 2- (4- (4- methylpiperazin- 1- yl)phenyl)- 3H- imidazo(4,5- b)pyridin- 7- yl)piperazin- 1- yl)methyl)- 5- methylisoxazoleIBA 01/2021
1	IonophoresIBA 01/2020
1	ruxolitinibIBA 01/2020
1	salinomycinIBA 01/2020
1	AZD3463IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2020